OPKO Health Inc.

OPKO Health delivers broad diagnostics via BioReference Laboratories and advances specialty pharmaceuticals—Rayaldee for kidney disease, long‑acting growth hormone, and oncology immunotherapies—supported by global manufacturing platforms in the US, Europe, and Latin America.

Headquarters: United States (USA)

OPKO Health Inc. Logo
Company Profile
  • Employees: 2,997
  • HQ: Miami
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
OPK OPKO Health Inc.
Cap: 1.1B
EQUITY NMS USD US68375N1037 Active
📈
Home Login